National precision medicine cancer trial

During the end of 2023, representatives from the PCM program began to participate in the planning of a national Swedish cancer trial using precision medicine. A prospective, non-randomized, clinical trial evaluating the efficacy of commercially available anti-cancer drugs for patients with advanced cancer and diagnosed with potentially actionable alterations revealed by genomic testing.

The work was initiated within the network of “Testbed Sweden for Clinical Trials and Implementation of Precision Health in Cancer Care”, Test Bed Sweden for Precision Health in Cancer – Nollvision Cancer .

Publications

Position paper by PCM Program steering group members Eskil Degsell and Mats Brommels on the need for a change in perspective in the collaboration between patient, relatives and Health care providers.

Read more

Calendar

date icon

Datum: February 19, 2024

Plats:

Information: CaReKI PI-retreat

more info
date icon

Datum: February 5, 2024

Plats: IRCCS - Istituto Nazionale dei Tumori, Milano

Information: Cancer Core Europe’s Annual Meeting 2024

more info
date icon

Datum: January 31, 2024

Plats: Life City, Solnavägen 3H, Solna

Information: Panel: The future of health: How can patient reported data lead to improved treatments?

more info